Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
View ORCID ProfileLisa Seekircher, Anita Siller, Manfred Astl, View ORCID ProfileLena Tschiderer, Gregor A. Wachter, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, View ORCID ProfilePeter Willeit
doi: https://doi.org/10.1101/2022.07.28.22278141
Lisa Seekircher
1Clinical Epidemiology Team, Medical University of Innsbruck, 6020 Innsbruck, Austria
Anita Siller
2Central Institute for Blood Transfusion and Immunology, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
Manfred Astl
2Central Institute for Blood Transfusion and Immunology, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
Lena Tschiderer
1Clinical Epidemiology Team, Medical University of Innsbruck, 6020 Innsbruck, Austria
3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
Gregor A. Wachter
2Central Institute for Blood Transfusion and Immunology, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
Bernhard Pfeifer
4Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
5Division for Healthcare Network and Telehealth, UMIT-Private University for Health Sciences, Medical Informatics and Technology GmbH, 6060 Hall, Austria
Andreas Huber
4Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
Manfred Gaber
6Blood donor service Tyrol of the Austrian Red Cross, 6063 Rum, Austria
Harald Schennach
2Central Institute for Blood Transfusion and Immunology, Tirol Kliniken GmbH, 6020 Innsbruck, Austria
Peter Willeit
1Clinical Epidemiology Team, Medical University of Innsbruck, 6020 Innsbruck, Austria
7Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK
Data Availability
Tabular data on the blood donor cohort can be requested from the corresponding authors by researchers who submit a methodologically sound proposal (including a statistical analysis plan); participant-level data on the blood donor cohort cannot be shared due to regulatory restrictions.
Posted July 31, 2022.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
Lisa Seekircher, Anita Siller, Manfred Astl, Lena Tschiderer, Gregor A. Wachter, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit
medRxiv 2022.07.28.22278141; doi: https://doi.org/10.1101/2022.07.28.22278141
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: Updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022
Lisa Seekircher, Anita Siller, Manfred Astl, Lena Tschiderer, Gregor A. Wachter, Bernhard Pfeifer, Andreas Huber, Manfred Gaber, Harald Schennach, Peter Willeit
medRxiv 2022.07.28.22278141; doi: https://doi.org/10.1101/2022.07.28.22278141
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2961)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (472)
- Neurology (4384)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6969)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)